CGA-IGC

📢 Calling Early-career researchers‼️ ➡️Apply for a one-year, $15,000 CGA-IGC & Fight CRC grant! 🔬 📍Supports research, QI & community engagement advancing care or advocacy in hereditary/familial colorectal cancer. 🧬 🎓 Trainees & investigators ≤5 years post-training eligible. 📅 Deadline - Friday, July 17, 2027 👉🔗Read the RFA & apply here cgaigc.com/grant-opportun… 👏 Thank you to @FightCRC for their continued support! #HereditaryGICacer #ColorectalCancer

🎙️ New CGA-IGC Podcast Episode! NCCN guideline panel members Samir Gupta, MD (@samirguptaGI), Jennifer Weiss, MD, MS, and Rachel Hodan, MS, CGC, join host @josiebakerGC to discuss key updates in Version 1.2026 of the NCCN Guidelines Update - Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, Esophageal, and Gastric Cancer 🎧 Listen here 👉 🔗cgaigc.com/podcast/episod… Topics include: 🧬 Expanded multigene panel testing 📋 Category 2B recommendations for colorectal and gastric cancers diagnosed at age 50 or older 🌍 Testing access and implementation challenges 🔄 More flexible pathways to guideline-based care #HereditaryGICancer #HereditaryCanceritaryCancer

📢 Join Memorial Sloan Kettering Cancer Center for "Hereditary Cancer Genetics: Incorporation into Clinical Care," a two-day symposium on clinical cancer genetics. 🗓️ Sept. 17–18, 2026 📍 In person & virtual 🧬 Expert faculty, panels & case-based sessions 🎓 CE credits available ➡️Learn more and register here 👉🔗mskcc.cloud-cme.com/course/courseo… #HereditaryGICancer #HereditaryCancer #Genetics

📢 Research Grant Deadline Extended: Friday, July 17, 2026! ‼️The deadline to apply for CGA-IGC research grants has been extended. Awards include: 🔹 CGA-IGC & CCARE Lynch Syndrome Research Award 🔹 CGA-IGC & @FightCRC Early Career Award 🔹 CGA-IGC & Roxanne and Henry Brandt Foundation Award for Familial Adenomatous Polyposis Research 💡CGA-IGC grants support projects that advance research, clinical care, quality improvement, advocacy, & patient or community engagement for individuals & families affected by hereditary gastrointestinal cancer syndromes. ➡️This is your final opportunity to apply. 📍View the RFA and application details: 👉🔗cgaigc.com/grant-opportun… #HereditaryCancer #HereditaryGICancer #LynchSyndrome #FamilialAdenomatousPolyposis #CancerResearch #ResearchFunding #EarlyCareerResearchers #GrantOpportunity @MattYurgelun @josiebakerGC

🚨 Travel Grant applications are open for #CGAIGC26! CGA-IGC is offering seven $2,000 travel grants to help support in-person attendance at the 2026 Annual Meeting in Denver. Opportunities are available for trainees, early career professionals in hereditary gastrointestinal cancer, allied health professionals, and CGA-IGC members working in Latin America. 📅 Application deadline: July 24, 2026 🔗 Learn more and apply: bit.ly/4eLDN5v

DEADLINE EXTENDED! You now have until Friday, July 10 to nominate your own Jeopardy team of 3 players for #CGAIGC26 in Denver 🔗 bit.ly/4xPvayq

📣In partnership with @FightCRC, CGA-IGC is offering research, quality improvement or community engagement project awards that advance science, clinical care, or advocacy for patients with #hereditary or familial #colorectalcancer syndromes. 🚨Deadline Friday, July 10, 2026 📍 Visit cgaigc.com/grant-opportun… for the RFA & application form Many 🙏to @FightCRC for their generous support! #HereditaryGICancer

📣 Happening tomorrow — July 1! Last chance to RSVP. Join Webinar 1 in our new 3-part research series exploring the “research story” behind real projects in hereditary GI cancer. 🧬 🎤 Timothy Yen, MD 📌 “Familial Colorectal Cancer Risk Among Those with Advanced Colorectal Polyps” 🗓️ July 1, 2026 ⏰ 5 PM ET / 2 PM PT ➡️RSVP here 👉 🔗evt.to/kqljmb35g3y0 Dr. Yen will share how the everyday challenge of managing pathology results helped reveal an important research gap. ➕ Add even more value to your #CGAIGC26 experience! Join us for the complimentary CGA-IGC Research Bootcamp, ahead of the Annual Meeting in Denver. 🗓️ Sunday, Nov. 1, 2026 ⏰ 12:00–1:45 PM MT 🏨 Denver, CO ➡️Learn more & RSVP 👉🔗 evt.to/t6jkv4srx0jg This interactive session is designed for registered annual meeting attendees at all stages of the research journey, from those new to research to those developing or leading projects. #HereditaryGICancer #CGAIGC26 @josiebakerGC

📣Did you miss our May #CGAIGCJS Tweetorial on “Daraxonrasib or Chemotherapy in Previously Treated Metastatic #PancreaticCancer”? Read the excellent tweetorial below by our Communications Committee member @AlexMannucci, who breaks down the article and key takeaways. #HereditaryGICancer

🌈 As Pride Month comes to a close, CGA-IGC shares a special podcast on inclusive, affirming care for LGBTQIA+ patients in hereditary GI cancer. The episode explores data gaps, privacy/documentation, and safer, patient-centered care. 🎙️ Listen here👉🔗cgaigc.com/podcast/episod… 📝 Read the accompanying blog post here 🔗 👉 cgaigc.com/post/affirming…, written by CGA-IGC Communications Committee member @ckurpad #PrideMonth #HereditaryGICancer @josiebakerGC

🧠 Think your team has what it takes to win CGA-IGC Jeopardy? Submit your team of 3 for the annual Jeopardy session at #CGAIGC26 and take your shot at challenging the defending champions, The Uninhibited Checkpoints, in Denver. Multidisciplinary teams from different institutions are encouraged, so gather your colleagues and get ready for a fun, fast-paced battle of knowledge! ⏰ Deadline to submit your team: Friday, June 26 Submit now: bit.ly/4xPvayq

📣 Haven't had the time to explore our monthly journal scan yet? ➡️ What is the key clinical takeaway from the EXONERATE-TRaCE study, & how could it impact clinical practice? 🎥 Watch the discussion with one of the lead authors, Dr. @AlexMannucci, & senior author, Professor Ajay Goel to learn more about the key clinical findings of the EXONERATE-TRaCE study, how liquid biopsy may help predict and monitor response to anti-EGFR therapy, and what this could mean for earlier detection of treatment resistance in metastatic colorectal cancer. 📍 Watch it here 👉🔗 youtu.be/Lo7JaosuFnA 📌 Read the article here 👉 🔗 pubmed.ncbi.nlm.nih.gov/42150147/ #HereditaryGICancer @MSpringerGC @AjayBansal_KUMC @asaf_maoz @EdEsplin @MLaszkowskaMD @MattYurgelun @anoushkaduaMD

9/🙏 & tune in every month for #CGAIGC Communications committee tweetorials on publications that impact our #HereditaryGICancer patients. ➡️Want a curated Journal Scan for #HereditaryGICancer 📨every month to your 📥every month? Become a CGA Member here 👉🔗cgaigc.com/copy-of-about #HereditaryGICancer

8/➡️What’s Next? 🚀Daraxonrasib is a first-in-class treatment option. 🚀Future promises include combining daraxonrasib with single-mutation KRAS drugs for longer lasting benefits, while paving the way to target other undruggable proteins (like MYC, p53, and β-catenin). nejm.org/doi/10.1056/NE…

1/Welcome to the May #CGAIGCJS Tweetorial on “Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer,” by CGA-IGC Communications committee member @AlexMannucci ➡️Full article in @NEJM pubmed.ncbi.nlm.nih.gov/42223072/ 🧵 #HereditaryGICancer